Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Kamada Ltd.    KMDA   IL0010941198

KAMADA LTD.

(KMDA)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Kamada: 1Q Earnings Snapshot

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/14/2019 | 07:19am EDT

REHOVOT, Israel (AP) _ Kamada Ltd. (KMDA) on Tuesday reported first-quarter profit of $4.9 million.

The Rehovot, Israel-based company said it had net income of 12 cents per share. Earnings, adjusted for stock option expense, came to 13 cents per share.

The biopharmaceutical posted revenue of $26.8 million in the period.

Kamada expects full-year revenue in the range of $125 million to $130 million.

Kamada shares have risen 13% since the beginning of the year. The stock has climbed 21% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KMDA at https://www.zacks.com/ap/KMDA

Automated Insights, source Associated Press News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on KAMADA LTD.
09/24Kamada to Present Corporate Overview at the 2019 Cantor Global Healthcare Con..
GL
09/03Kamada Announces Extension of GLASSIA® [Alpha1-Proteinase Inhibitor (Human)] ..
GL
08/08Kamada Reports Discussions with Takeda Regarding a Potential Extension of the..
GL
08/06KAMADA : 2Q Earnings Snapshot
AQ
08/06Kamada Reports Financial Results for Second Quarter and First Six Months of 2..
GL
07/31KAMADA : to Report Second Quarter 2019 Financial Results and Host Conference Cal..
AQ
05/14KAMADA : 1Q Earnings Snapshot
AQ
05/14KAMADA : Reports Financial Results for First Quarter of 2019
AQ
05/07KAMADA : to Report First Quarter 2019 Financial Results and Host Conference Call..
AQ
04/16KAMADA : announces FDA acceptance of Inhaled AAT program path forward
AQ
More news
Financials (ILS)
Sales 2019 449 M
EBIT 2019 77,7 M
Net income 2019 70,5 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020 -
Capi. / Sales2019 1,65x
Capi. / Sales2020 1,54x
Capitalization 738 M
Chart KAMADA LTD.
Duration : Period :
Kamada Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KAMADA LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 18,25  
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Amir London Chief Executive Officer
Leon Y. Recanati Chairman
Eran Nir Vice President-Operations
Chaime Orlev Chief Financial Officer
Naveh Tov Vice President-Clinical Development
Sector and Competitors
1st jan.Capitalization (M$)
KAMADA LTD.-2.35%208
CSL LIMITED36.42%77 980
BIOGEN INC.-26.87%40 589
ALEXION PHARMACEUTICALS2.70%22 066
SAMSUNG BIOLOGICS CO LTD--.--%19 301
GRIFOLS19.13%18 295